Role of major histocompatibility complex class-I molecules in tumor rejection. New insights from studies with synthetic peptides and transgenic mice
- PMID: 2089075
- DOI: 10.1007/BF02935529
Role of major histocompatibility complex class-I molecules in tumor rejection. New insights from studies with synthetic peptides and transgenic mice
Similar articles
-
Rejection of tumors in mice with severe combined immunodeficiency syndrome determined by the major histocompatibility complex. Class I expression on the graft.Cancer Res. 1995 May 1;55(9):1911-6. Cancer Res. 1995. PMID: 7728758
-
The RMA-S lymphoma mutant; consequences of a peptide loading defect on immunological recognition and graft rejection.Int J Cancer Suppl. 1991;6:38-44. doi: 10.1002/ijc.2910470711. Int J Cancer Suppl. 1991. PMID: 2066183
-
MHC gene control of the natural killer system at the level of the target and the host.Semin Cancer Biol. 1991 Oct;2(5):295-309. Semin Cancer Biol. 1991. PMID: 1773046 Review.
-
Transgenic expression of the Ly49A natural killer cell receptor confers class I major histocompatibility complex (MHC)-specific inhibition and prevents bone marrow allograft rejection.J Exp Med. 1996 Nov 1;184(5):2037-41. doi: 10.1084/jem.184.5.2037. J Exp Med. 1996. PMID: 8920892 Free PMC article.
-
Influence of major histocompatibility complex class I, class II and TLA genes on tumor rejection.Semin Cancer Biol. 1991 Oct;2(5):311-9. Semin Cancer Biol. 1991. PMID: 1773047 Review.
Cited by
-
Increased projection of MHC and tumor antigens in murine B16-BL6 melanoma induced by hydrostatic pressure and chemical crosslinking.Cancer Immunol Immunother. 1993 May;36(5):293-9. doi: 10.1007/BF01741167. Cancer Immunol Immunother. 1993. PMID: 8477415 Free PMC article.
-
Molecular anatomy of viral persistence.J Virol. 1991 Dec;65(12):6381-6. doi: 10.1128/JVI.65.12.6381-6386.1991. J Virol. 1991. PMID: 1719227 Free PMC article. Review. No abstract available.